Moderna, Inc.

MRNA

Biotech & pharmaceuticals

$134.42vs prev close▼-10.71(-7.38%)

$22.2852W Range$176.66

73% from low

+91.06 (+168.41%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

No trades in 1M

1M net buy

≈ 0 shares

Portfolio Weight

0.00%

1M -0.31%p

Holding ETFs

1 ETFs

ARKG

Sell · Weight Down

ARK net-sold the stock and the price fell, decreasing its portfolio weight.

Shares -100.0% · Market value -100.0% · Weight -0.31%p

Trade Intensity

No trades in 1M

Trade Log

Date	Action	ETF	Shares	Close	Est. total
24.11.21	SELL	ARKG	91	$38.25	$3.5K
24.11.20	SELL	ARKG	277	$36.94	$10.2K
24.11.14	SELL	ARKG	2,859	$39.77	$113.7K
24.11.12	SELL	ARKG	12,038	$43.47	$523.3K
24.11.08	SELL	ARKG	43,810	$46.83	$2.1M
24.11.07	SELL	ARKG	86,673	$50.28	$4.4M
24.11.06	SELL	ARKG	49,922	$51.81	$2.6M
24.11.05	SELL	ARKK	360	$53.29	$19.2K
24.11.04	SELL	ARKG	13,360	$53.54	$715.3K
24.11.01	SELL	ARKG · ARKK	18,580	$54.63	$1.0M
24.10.31	SELL	ARKK	50,200	$54.36	$2.7M
24.10.30	SELL	ARKK	79,988	$54.72	$4.4M
24.10.29	SELL	ARKK	23,013	$55.22	$1.3M
24.10.23	SELL	ARKG · ARKK	19,006	$53.39	$1.0M
24.10.22	SELL	ARKG · ARKK	157,421	$53.40	$8.4M

11.21SELL

ARKGClose$38.25Est. total$3.5K

11.20SELL

277

ARKGClose$36.94Est. total$10.2K

11.14SELL

2,859

ARKGClose$39.77Est. total$113.7K

11.12SELL

12,038

ARKGClose$43.47Est. total$523.3K

11.08SELL

43,810

ARKGClose$46.83Est. total$2.1M

11.07SELL

86,673

ARKGClose$50.28Est. total$4.4M

11.06SELL

49,922

ARKGClose$51.81Est. total$2.6M

11.05SELL

360

ARKKClose$53.29Est. total$19.2K

11.04SELL

13,360

ARKGClose$53.54Est. total$715.3K

11.01SELL

18,580

ARKG · ARKKClose$54.63Est. total$1.0M

10.31SELL

50,200

ARKKClose$54.36Est. total$2.7M

10.30SELL

79,988

ARKKClose$54.72Est. total$4.4M

10.29SELL

23,013

ARKKClose$55.22Est. total$1.3M

10.23SELL

19,006

ARKG · ARKKClose$53.39Est. total$1.0M

10.22SELL

157,421

ARKG · ARKKClose$53.40Est. total$8.4M

1 / 3

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

2 Holding · 1 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Philippe LaffontCoatue Management

New Buy

200,000

Portfolio Weight

0.17%

Est. Value

$6M

Change

New position

Ray DalioBridgewater Associates

Decreased

15,181

Portfolio Weight

Est. Value

$448K

vs Prev Quarter

-93% (222K→15K)

Sold · Q4 2025

Cathie WoodARK Invest

Fully Sold

Portfolio Weight

Prev Holdings

Est. Sold Value

$3K

Holding Period

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Targets

avg.

$91.39

vs Current ▼ -37.0% downside

Current$145.13

Low ~ High$25.00 ~ $170.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

JP Morgan

Underweight

$77.00

-46.94%

—

Maintain

2026-08-21

Goldman Sachs

Neutral

$120.00

-17.32%

—

Maintain

2026-08-20

UBS

Neutral

$150.00

+3.36%

—

Maintain

2026-08-20

Morgan Stanley

Equal-Weight

$89.00

-38.68%

—

Maintain

2026-08-20

William Blair

Outperform

N/A

—

Upgrade

2026-08-19

1 / 4

Avg Target

$91.39

vs Current ▼ -37.0% downside

Hold

23 analysts

Strong Buy 1Buy 3Hold 17Sell 1Strong Sell 1

Low $25.00

Current $145.13

High $170.00

Firm	Position	Target	Upside	Close	Action	Date
JP Morgan	Underweight	$77.00	-46.94%	—	Maintain	26.08.21
Goldman Sachs	Neutral	$120.00	-17.32%	—	Maintain	26.08.20
UBS	Neutral	$150.00	+3.36%	—	Maintain	26.08.20
Morgan Stanley	Equal-Weight	$89.00	-38.68%	—	Maintain	26.08.20
William Blair	Outperform	N/A	N/A	—	Upgrade	26.08.19

1 / 4

Price Information

Previous Close$133.32

Open$132.50

Day Range$132.43 - $159.47

52-Week Range$22.28 - $176.66

1-Year Change472.50%

Trading Volume

Volume87,316,065

Avg Volume (3mo)12,883,224

Valuation

Market Cap57.9B

Book Value$16.95

Shares Outstanding399,235,889

Financials

Revenue (TTM)2.2B

Net Income-3,151,000,064

EPS$-7.98

EBITDA-2,195,000,064

Profitability

P/E Ratio-

P/B Ratio8.56

Return on Equity (ROE)-39.00%

Return on Assets (ROA)-13.26%

Profit Margin-141.43%

EV/EBITDA-24.64

Beta0.90

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)74.71

Company Overview

Moderna, Inc. is a biotechnology company that develops and commercializes messenger RNA (mRNA) medicines. Its main products include respiratory vaccines like Spikevax (COVID-19) and mRESVIA (RSV), as well as vaccines for latent viruses, enteric viruses, public health threats, and bacterial diseases. Moderna also offers oncology therapeutics and rare disease treatments, positioning itself as a leader in mRNA-based therapies.

P/B

8.56

High valuation

ROE

-39.0%

Persistent loss

Beta

0.90

Market level

RSI(14)

74.7

Overbought

AI-generated summary. Not investment advice.

Moderna, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks